Ares Commercial Real Estate Cor (ACRE) 12.17 $ACRE Ares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ares Commercial Real Estate Cor (ACRE) 12.17 $ACRE

Ares Commercial Real Estate Corporation to Present at the Keefe, Bruyette & Woods 2016 Mortgage Finance Conference
BusinessWire - Thu May 26, 3:15PM CDT
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that its Co-Chief Executive Officer and President, John Jardine, and its Chief Financial Officer, Tae-Sik Yoon will present at the Keefe, Bruyette & Woods 2016 Mortgage Finance Conference in New York, NY on Wednesday, June 1, 2016 at 2:40 pm ET.
ARES: 13.66 (-0.25), ACRE: 12.17 (-0.02)

Ares Commercial Real Estate posts 1Q profit
Automated Insights - Thu May 05, 5:44AM CDT
NEW YORK (AP) _ Ares Commercial Real Estate Corp. (ACRE) on Thursday reported first-quarter net income of $5.1 million.
ACRE: 12.17 (-0.02)

Ares Commercial Real Estate Corporation Reports First Quarter 2016 Results
BusinessWire - Thu May 05, 5:30AM CDT
--- Subsequent to end of first quarter -
ARES: 13.66 (-0.25), ACRE: 12.17 (-0.02)

Ares Commercial Real Estate Corporation Schedules Earnings Release for the First Quarter 2016
BusinessWire - Wed Apr 27, 5:30AM CDT
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it will release financial results for the first quarter 2016 on Thursday, May 5, 2016 prior to the opening of the New York Stock Exchange. The Company invites all interested persons to attend its webcast/conference call at 12:00 p.m. (Eastern Time) on the same day to discuss its first quarter 2016 financial results.
ARES: 13.66 (-0.25), ACRE: 12.17 (-0.02)

Ares Commercial Real Estate Corporation Announces Appointments of Two New Independent Directors
BusinessWire - Tue Apr 26, 3:15PM CDT
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it has appointed Rand S. April and James E. Skinner to its board as independent directors.
ARES: 13.66 (-0.25), ACRE: 12.17 (-0.02)

Ares Commercial Real Estate (ACRE) is in Overbought Territory: What's Next?
Zacks Equity Research - Zacks Investment Research - Fri Apr 15, 7:47AM CDT
Ares Commercial Real Estate Corporation (ACRE) has moved higher as of late, but there could definitely be trouble on the horizon for this company
ACRE: 12.17 (-0.02)

New Strong Sell Stocks for April 8th
Zacks Equity Research - Zacks Investment Research - Fri Apr 08, 7:34AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
ACPW: 0.52 (-0.01), AFOP: 18.51 (+0.01), ACSF: 10.57 (+0.07), ATRS: 1.05 (unch), ACRE: 12.17 (-0.02)

Ares Commercial Real Estate Corporation Announces Tax Reporting Information for Calendar Year 2015
BusinessWire - Fri Jan 29, 7:00AM CST
Ares Commercial Real Estate Corporation (NYSE:ACRE) (the "Company" today announced the tax treatment for the Company's dividends on its common stock (CUSIP # 04013V-10-8) for calendar year 2015.
ARES: 13.66 (-0.25), ACRE: 12.17 (-0.02)

Ares Commercial Real Estate Corporation Closes New Secured Term Loan to Fund Future Growth
BusinessWire - Mon Dec 14, 5:30AM CST
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it has closed a new $155.0 million secured term loan. The loan has a term of three years and proceeds will be used to fund new loan originations as well as for other general corporate purposes. The company made an initial draw of $75.0 million at closing with the remaining $80.0 million to be funded within nine months of closing. The term loan carries a coupon of LIBOR + 6.0% with a LIBOR floor of 1.0% on drawn amounts. In addition, there are fees on undrawn amounts and discounts on amounts funded.
ARES: 13.66 (-0.25), ACRE: 12.17 (-0.02)

Ares Commercial Real Estate Corporation Reports Third Quarter 2015 Results
BusinessWire - Thu Nov 05, 5:00AM CST
--Originated new commitments of $230 million
ARES: 13.66 (-0.25), ACRE: 12.17 (-0.02)

Ares Commercial Real Estate Corporation Schedules Earnings Release for the Third Quarter 2015
BusinessWire - Wed Oct 28, 5:30AM CDT
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it will release financial results for the third quarter 2015 on Thursday, November 5, 2015 prior to the opening of the New York Stock Exchange. ACRE invites all interested persons to attend its webcast/conference call at 12:00 p.m. (Eastern Time) to discuss its third quarter 2015 financial results.
ARES: 13.66 (-0.25), ACRE: 12.17 (-0.02)

American Capital Q3 Earnings Miss, Book Value Diminishes
Zacks Equity Research - Zacks Investment Research - Tue Oct 27, 9:40AM CDT
American Capital Agency Corp. (AGNC) reported third-quarter 2015 net spread and dollar roll income of 51 cents per share, missing the Zacks Consensus Estimate of 60 cents.
RSO: 12.65 (-0.26), ACAS: 16.03 (+0.06), AGNC: 18.77 (-0.12), ACRE: 12.17 (-0.02)

New Strong Buy Stocks for August 4th - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 04, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
ACRX: 3.07 (-0.12), AAWW: 44.70 (-1.32), ASC: 8.45 (-0.25), AI: 13.34 (-0.36), ACRE: 12.17 (-0.02)

Ares Commercial Real Estate Corporation Reports Second Quarter 2015 Results
BusinessWire - Thu Jul 30, 7:00AM CDT
--Declared third quarter 2015 dividend of $0.25 per common share
ARES: 13.66 (-0.25), ACRE: 12.17 (-0.02)

American Tower Q2 Earnings, Revenues Lag; Outlook Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 29, 1:45PM CDT
American Tower Corp. (AMT) reported poor financial numbers for the second quarter of 2015, with both the top and the bottom line missing the Zacks Consensus Estimate
ARR: 19.40 (-0.54), AMT: 108.93 (+0.14), ARI: 16.38 (-0.11), ACRE: 12.17 (-0.02)

American Capital Agency Misses in Q2, Book Value Falls - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 9:10AM CDT
American Capital Agency Corp. (AGNC) reported second-quarter 2015 net spread and dollar roll income of 60 cents per share, missing the Zacks Consensus Estimate by 2 cents.
ACAS: 16.03 (+0.06), AGNC: 18.77 (-0.12), ACRE: 12.17 (-0.02), ZFC: 14.15 (-0.02)

Ares Commercial Real Estate Corporation Schedules Earnings Release for the Second Quarter 2015
BusinessWire - Wed Jul 22, 3:15PM CDT
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it will release financial results for the second quarter 2015 on Thursday, July 30, 2015 prior to the opening of the New York Stock Exchange. ACRE invites all interested persons to attend its webcast/conference call at 12:00 p.m. (Eastern Time) to discuss its second quarter 2015 financial results.
ARES: 13.66 (-0.25), ACRE: 12.17 (-0.02)

The Zacks Analyst Blog Highlights: Avago Technologies, Broadcom, EQT Midstream Partners, Ares Commercial Real Estate and Essent Group - Press Releases
Zacks Equity Research - Zacks Investment Research - Wed Jul 08, 8:30AM CDT
The Zacks Analyst Blog Highlights: Avago Technologies, Broadcom, EQT Midstream Partners, Ares Commercial Real Estate and Essent Group
BRCM: 54.67 (+0.17), EQM: 73.97 (-0.01), ESNT: 21.73 (unch), ACRE: 12.17 (-0.02), AVGO: 160.01 (-0.81)

Boring Can Be Smart with These Dividend Growth Stocks - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 07, 5:22PM CDT
A lot of investors consider dividend-paying companies as "boring."
ROIC: 20.66 (-0.19), CHD: 99.14 (-0.74), RCL: 72.88 (-1.05), CFI: 28.90 (-0.10), ACRE: 12.17 (-0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading